cerrar
Tagged with Opinion

The Evolution of Medical Cannabis Legislation in Canada
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its current legal status, provincial…

San Diego: What it Takes to be a Successful Life Science…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020 conference on why San Diego offers…

Aducanumab edges closer to Potential Approval: Next up, the…
In his latest piece on Alzheimer’s Disease (AD) drug Aducanumab’s winding journey to market, Dr Neil Cashman looks forward to the US FDA Advisory…

Emerging Markets: How COVID-19 is Throwing New Light on the Role…
Dr Ann Aerts, head of the Novartis Foundation, highlights how the COVID-19 crisis has thrust artificial intelligence in healthcare into the limelight,…

Importing Drugs from Canada: America’s Zombieland Sequel
Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from Canada and why such proposals retain…

PhRMA CEO on ‘Tireless’ Industry COVID-19 Response &…
Stephen J. Ubl, president and CEO of PhRMA, outlines the unprecedented collaboration and speed with which the biopharmaceutical industry has responded…

Cell & Gene Therapy: Command? Consent? Collaborate!
Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T therapies to make the case for the…

Utilising Data-Science to Boost US Market Access in Volatile…
Dr Philipp Diesinger and Dr Gabriell Máté outline why a data-driven approach can help optimise patient copay assistance programs in the US across a…

Japan: The Latest Therapeutic Applications in Induced Pluripotent…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan over a decade ago is poised to drive…

Asia-Pacific: Hiring the Right Healthtech CFO Can Be Tough; It…
Robert Hall of Hong Kong-based executive recruitment specialist Ardent Search highlights the key traits and experiences that Asian biotech and medtech…

Pharmacovigilance: Steadying the Ship Through the COVID-19 Storm
Michael Levy, head of pharmacovigilance at Bayer Pharma and Bayer Consumer Health, makes a compelling case for the critical role of pharmacovigilance…

Paying for Cell & Gene Therapy in the USA: Is the Future…
Certara’s Ulrich Neumann looks at the challenges that payment models for cell and gene therapy (CGT) have faced, the multiple models now under…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here